Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11345654 Polymorphic compounds and uses thereof

Patent 11345654 was granted and assigned to Navitor Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Navitor Pharmaceuticals

Current Assignee

Navitor Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113456540

Patent Inventor Names

Silvia Lenzini0

Date of Patent

May 31, 2022

Patent Application Number

166625170

Date Filed

October 24, 2019

Patent Citations

‌

US Patent 10752644 Modulators of Sestrin-GATOR2 interaction and uses thereof

‌

US Patent 10100066 Modulators of sestrin-GATOR2 interaction and uses thereof

‌

US Patent 10414782 Modulators of sestrin-GATOR2 interaction and uses thereof

‌

US Patent 10912750 Modulators of Sestrin-GATOR2 interaction and uses thereof

Patent Primary Examiner

CPC Code

The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11345654 Polymorphic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API